Kataneh Maleki, MD
Clinical Cardiac Electrophysiology · Edison, NJNPI 1396706651
Payments from drug & device makers
Across 213 payments — averaging $47.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$2K
- Abbott$859
- Biotronik Inc.$398
- Biosense Webster, Inc.$340
- E.r. Squibb & Sons, L.L.C.$272
- plus $2K from 30 others
What the payments were for
- Travel & lodging$3,40334%
- Food & beverage$6,61766%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 59 | $4,104 |
| Boston Scientific | 30 | $1,865 |
| Abbott | 14 | $859 |
| Biotronik Inc. | 6 | $398 |
| Biosense Webster, Inc. | 4 | $340 |
| E.r. Squibb & Sons, L.L.C. | 15 | $272 |
| Johnson & Johnson | 10 | $268 |
| Cvrx, Inc. | 8 | $253 |
| Cardiva Medical, Inc. | 7 | $208 |
| Pfizer | 13 | $195 |
| Sanofi-aventis U.S. LLC | 9 | $134 |
| Impulse Dynamics (USA) Inc. | 1 | $125 |
| ZOLL Respicardia, Inc. | 1 | $119 |
| Edwards Lifesciences | 1 | $111 |
| Penumbra, Inc. | 1 | $107 |
| Abiomed | 2 | $82 |
| Merck | 5 | $72 |
| Baxter Healthcare | 2 | $71 |
| Novartis | 3 | $52 |
| Shockwave Medical, Inc | 1 | $47 |
| Amarin Pharma, Inc. | 3 | $43 |
| Amgen | 3 | $43 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $28 |
| Atricure, Inc. | 1 | $28 |
| Altathera Pharmaceuticals LLC | 1 | $24 |
| Renalytix AI, Inc. | 1 | $20 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Avanos Medical | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$692
- Paceart$479
- Ensite Cardiac Mapping System$455
- SQ RX PULSE GENERATOR$393
- Amplia MRI$340
- GENERAL - THERAPIES$298
- OPTIMIZER$250
- EMBLEM MRI S-ICD$143
- Watchman$143
- SelectSecure$141
- GENERAL TACHY$132
- Fortify Assura, Ellipse ICD$129
- Barostim Neo System$128
- Carto Smarttouch$122
- CareLink$122
- remede System$119
- GENERAL EP$118
- Edwards SAPIEN 3 Transcatheter Heart Valve$111
- CAPSUREFIX NOVUS MRI SURESCAN$110
- Carto 3$110
How this compares
$10,020 in reported general payments places this provider in the 25th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 211 | $232,003 |
| XareltoRivaroxaban | 73 | $66,925 |
| MultaqDronedarone Hcl | 50 | $57,925 |
| EntrestoSacubitril/Valsartan | 33 | $47,659 |
| FarxigaDapagliflozin Propanediol | 28 | $19,361 |
| Dofetilide | 60 | $10,657 |
| Mexiletine Hcl | 52 | $4,401 |
| Flecainide Acetate | 88 | $4,132 |
| SotalolSotalol Hcl | 196 | $3,752 |
| Metoprolol Succinate | 91 | $2,181 |
| Midodrine Hcl | 18 | $1,464 |
| Metoprolol Tartrate | 118 | $1,006 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 32 | $671 |
| Dilt-XrDiltiazem Hcl | 15 | $575 |
| Digoxin | 22 | $574 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $195 | $232,003211 claims |
| Johnson & JohnsonXarelto | $268 | $66,92573 claims |
| Sanofi-aventis U.S. LLCMultaq | $134 | $57,92550 claims |
| NovartisEntresto | $52 | $47,65933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Edison
- Suneet MittalParamus$2.3M
- Benjamin D SouzaCherry Hill$1.2M
- George MarkHaddon Heights$935K
- Sanjeev SaksenaWarren$911K
- Darius SholevarCherry Hill$843K
- Jonathan SteinbergRidgewood$490K
- Emad AzizNewark$350K
- Mark MascarenhasEatontown$324K
- Dan MusatRidgewood$321K
- Jonathan SussmanMorristown$292K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.